Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

What symbol and exchange does Evolus shares trade?

Evolus trades on the NASDAQ stock market under the symbol EOLS.

What is Evolus stock price doing today?

As of October 22, 2026, EOLS stock price climbed to $7.41 with 601,702 million shares trading.

What is Evolus's Beta?

EOLS has a beta of 1.82, meaning it tends to be more sensitive to market movements. EOLS has a correlation of 0.12 to the broad based SPY ETF.

How much is Evolus worth?

EOLS has a market cap of $489.43 million. This is considered a Small Cap stock.

How much money does Evolus make?

Last quarter Evolus reported $84 million in Revenue and -$.12 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.07.

What is the highest and lowest price Evolus traded in the last 3 year period?

In the last 3 years, EOLS traded as high as $17.82 and as low as $3.86.

What are the top ETFs holding Evolus?

The top ETF exchange traded funds that EOLS belongs to (by Net Assets): VTI, IWM, VXF, IWO, XPH.

Is Evolus (EOLS) a good investment?

EOLS has underperformed the market in the last year with a price return of +8.7% while the SPY ETF gained +15.5%. However, in the short term, EOLS had mixed performance relative to the market. It has outperformed in the last 3 months, returning +25.8% vs +2.5% return in SPY. But in the last 2 weeks, EOLS shares have been beat by the market, returning -5.0% compared to an SPY return of -1.3%.

What are the support and resistance levels for Evolus (EOLS)?

EOLS support price is $7.14 and resistance is $7.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EOLS shares will trade within this expected range on the day.